Literature DB >> 7539400

A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.

U Karsten1, G Butschak, Y Cao, S Goletz, F G Hanisch.   

Abstract

A new monoclonal antibody to the Thomsen-Friedenreich (TF) antigen (or, more precisely, epitope; Gal beta 1-3GalNAc-) has been developed that is specific for both anomeric forms of this disaccharide (TF alpha and TF beta, including related structures on glycolipids), and not assay restricted. We demonstrate that this avid antibody (A78-G/A7) is well suited for immunohistochemistry on paraffin-embedded and cryosectioned tissues, immunoblotting, ELISA techniques, and hemagglutination. Immunohistochemistry on paraffin sections does not require proteolytic or microwave pretreatment. The binding characteristics of this antibody are largely independent of variations in pH (6.0-8.2) and temperature (4-37 degrees C). Immunoblotting with KG-1 (human acute myelogenous leukemia) cells revealed a series of TF-active glycoproteins with a main band at about 155 kDa. Immunoprecipitation was performed using a new technique applicable to IgM-type antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539400     DOI: 10.1089/hyb.1995.14.37

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  11 in total

1.  Supplier-dependent antiglycan monoclonal antibody specificities: comment on "High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems".

Authors:  Jeff Gildersleeve; Timothy A Roach; Zhitao Li; Jeffrey C Gildersleeve
Journal:  Glycobiology       Date:  2008-06-06       Impact factor: 4.313

2.  Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.

Authors:  Y Cao; P Stosiek; G F Springer; U Karsten
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

3.  Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.

Authors:  Shilpa A Patil; Wiam Bshara; Carl Morrison; E V Chandrasekaran; Khushi L Matta; Sriram Neelamegham
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

4.  Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.

Authors:  Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

5.  Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.

Authors:  Udo Jeschke; Uwe Karsten; Irmi Wiest; Sandra Schulze; Christina Kuhn; Klaus Friese; Hermann Walzel
Journal:  Histochem Cell Biol       Date:  2006-04-11       Impact factor: 4.304

Review 6.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

7.  CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes.

Authors:  Jiangnan Liu; Bin Yi; Zhe Zhang; Yi Cao
Journal:  Front Med       Date:  2016-04-18       Impact factor: 4.592

8.  Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion.

Authors:  Udo Jeschke; Xiaoyu Wang; Volker Briese; Klaus Friese; Renate Stahn
Journal:  Histochem Cell Biol       Date:  2003-05-13       Impact factor: 4.304

9.  Binding of galectin-1 (gal-1) on trophoblast cells and inhibition of hormone production of trophoblast tumor cells in vitro by gal-1.

Authors:  Udo Jeschke; Toralf Reimer; Claudia Bergemann; Irmi Wiest; Sandra Schulze; Klaus Friese; Hermann Walzel
Journal:  Histochem Cell Biol       Date:  2004-06-08       Impact factor: 4.304

10.  What makes cancer stem cell markers different?

Authors:  Uwe Karsten; Steffen Goletz
Journal:  Springerplus       Date:  2013-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.